Masaomi Iyo - Search Results

Year	Number of Results
2002	8
2003	14
2004	25
2005	27
2006	24
2007	21
2008	23
2009	26
2010	21
2011	22
2012	11
2013	19
2014	14
2015	25
2016	14
2017	16
2018	11
2019	9
2020	19
2021	28
2022	9
2023	9
2024	4

1

Association of SLC6A3 variants with treatment-resistant schizophrenia: a genetic association study of dopamine-related genes in schizophrenia.

Kogure M, Kanahara N, Miyazawa A, Shiko Y, Otsuka I, Matsuyama K, Takase M, Kimura M, Kimura H, Ota K, Idemoto K, Tamura M, Oda Y, Yoshida T, Okazaki S, Yamasaki F, Nakata Y, Watanabe Y, Niitsu T, Hishimoto A, Iyo M. Kogure M, et al. Among authors: iyo m. Front Psychiatry. 2024 Feb 27;14:1334335. doi: 10.3389/fpsyt.2023.1334335. eCollection 2023. Front Psychiatry. 2024. PMID: 38476817 Free PMC article.

2

Cerebellar and Occipital Alterations in Brain Perfusion in a Patient With Post-acute COVID-19 Encephalopathy Misdiagnosed As Primary Psychotic Disorder.

Ikemizu Y, Oda Y, Hirose Y, Sasaki T, Iyo M. Ikemizu Y, et al. Among authors: iyo m. Cureus. 2024 Jan 25;16(1):e52953. doi: 10.7759/cureus.52953. eCollection 2024 Jan. Cureus. 2024. PMID: 38406081 Free PMC article.

3

Effectiveness of Brexpiprazole in a Patient With Bipolar Disorder and Comorbid Persistent Genital Arousal Disorder/Genito-Pelvic Dysesthesia: A Case Report.

Hirose Y, Oda Y, Kobayashi T, Okada K, Iyo M. Hirose Y, et al. Among authors: iyo m. Cureus. 2023 Dec 11;15(12):e50349. doi: 10.7759/cureus.50349. eCollection 2023 Dec. Cureus. 2023. PMID: 38205449 Free PMC article.

4

A retrospective clinical practice study comparing the usefulness of dual-orexin receptor antagonists and a melatonin receptor agonist in patients switching from long-term benzodiazepine receptor agonists.

Tachibana M, Kanahara N, Oda Y, Hasegawa T, Kimura A, Iyo M. Tachibana M, et al. Among authors: iyo m. J Clin Sleep Med. 2024 Apr 1;20(4):603-613. doi: 10.5664/jcsm.10946. J Clin Sleep Med. 2024. PMID: 38063235

5

Current practice for clozapine-induced leukopenia in Japanese psychiatric hospitals: A nationwide survey.

Niitsu T, Yasui-Furukori N, Inada K, Kanazawa T, Iyo M, Ueno T, Hashimoto R. Niitsu T, et al. Among authors: iyo m. Schizophr Res. 2023 Oct 27:S0920-9964(23)00372-9. doi: 10.1016/j.schres.2023.10.011. Online ahead of print. Schizophr Res. 2023. PMID: 38038428

6

Reduction of claudin-5 and aquaporin-4 in the rat hippocampal CA-1 and CA-3 regions of a learned helplessness model of depression.

Hirose Y, Oda Y, Yoshino K, Yano F, Kimura M, Kimura H, Iyo M, Shirayama Y. Hirose Y, et al. Among authors: iyo m. Pharmacol Biochem Behav. 2024 Jan;234:173676. doi: 10.1016/j.pbb.2023.173676. Epub 2023 Nov 21. Pharmacol Biochem Behav. 2024. PMID: 37992974

7

A pilot trial of an online guided self-help cognitive behavioral therapy program for bulimia nervosa and binge eating disorder in Japanese patients.

Ohsako N, Kimura H, Hashimoto T, Hosoda Y, Inaba Y, Iyo M, Nakazato M. Ohsako N, et al. Among authors: iyo m. Biopsychosoc Med. 2023 Nov 10;17(1):37. doi: 10.1186/s13030-023-00294-1. Biopsychosoc Med. 2023. PMID: 37950266 Free PMC article.

8

Can brexpiprazole be switched safely in patients with schizophrenia and dopamine supersensitivity psychosis? A retrospective analysis in a real-world clinical practice.

Yamasaki F, Kanahara N, Nakata Y, Koyoshi S, Yanagisawa Y, Saito T, Oiwa T, Kogure M, Sasaki T, Yoshida T, Kimura H, Iyo M. Yamasaki F, et al. Among authors: iyo m. J Psychopharmacol. 2023 Oct;37(10):992-1002. doi: 10.1177/02698811231177268. Epub 2023 Jul 3. J Psychopharmacol. 2023. PMID: 37395368

9

An exploratory database study of factors influencing the continuation of brexpiprazole treatment (prescription) in patients with schizophrenia using information from psychiatric electronic medical records processed with natural language processing.

Iyo M, Akiyoshi H, Sekine D, Shibasaki Y, Mamiya N. Iyo M, et al. Schizophr Res. 2023 May;255:122-131. doi: 10.1016/j.schres.2023.03.008. Epub 2023 Mar 27. Schizophr Res. 2023. PMID: 36989669 Free article.

10

Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia.

Masumo Y, Kanahara N, Kogure M, Yamasaki F, Nakata Y, Iyo M. Masumo Y, et al. Among authors: iyo m. Int Clin Psychopharmacol. 2023 Mar 1;38(2):102-109. doi: 10.1097/YIC.0000000000000442. Epub 2022 Nov 11. Int Clin Psychopharmacol. 2023. PMID: 36719338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

348 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

348 results

Results by year